{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:04:05Z","timestamp":1778007845810,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.psym.2020.05.006","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T02:28:17Z","timestamp":1589768897000},"page":"411-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Psychopharmacology of COVID-19"],"prefix":"10.1016","volume":"61","author":[{"given":"Melanie","family":"Bilbul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Paparone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Mutalik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie L.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psym.2020.05.006_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4742","article-title":"Treating COVID-19\u2014off-label drug use, compassionate use, and randomized clinical trials during pandemics","author":"Kalil","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.psym.2020.05.006_bib3","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S0140-6736(20)30558-4","article-title":"Comorbidities and multi-organ\u00a0injuries in the treatment of COVID-19","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.psym.2020.05.006_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.psym.2020.05.006_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.psym.2020.05.006_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0033-3182(99)71206-5","article-title":"Hematologic side effects of psychotropics","volume":"40","author":"Oyesanmi","year":"1999","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psym.2020.05.006_bib7","first-page":"200061","article-title":"Consensus statement on the use of clozapine during the COVID-19 pandemic","volume":"45","author":"Siskind","year":"2020","journal-title":"J\u00a0Psychiatry Neurosci"},{"key":"10.1016\/j.psym.2020.05.006_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/wps.20707","article-title":"Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics","volume":"19","author":"de Leon","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psym.2020.05.006_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: a systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.psym.2020.05.006_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/pgmj.2005.037515","article-title":"Cardiovascular complications of severe acute respiratory syndrome","volume":"82","author":"Yu","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.psym.2020.05.006_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.psym.2020.05.006_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.psym.2020.05.006_bib14","article-title":"SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes","author":"Wu","year":"2020","journal-title":"Hear\u00a0Rhythm"},{"key":"10.1016\/j.psym.2020.05.006_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psym.2017.10.009","article-title":"QT prolongation, torsades de Pointes, and psychotropic medications: a 5-year update","volume":"59","author":"Beach","year":"2018","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psym.2020.05.006_bib16","first-page":"521","article-title":"Gastrointestinal and liver\u00a0manifestations in patients with COVID-19","volume":"83","author":"Lee","year":"2020","journal-title":"J\u00a0Chin\u00a0Med\u00a0Assoc"},{"key":"10.1016\/j.psym.2020.05.006_bib17","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/liv.14449","article-title":"Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study","volume":"40","author":"Xie","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.psym.2020.05.006_bib18","series-title":"Managing the side effects of psychotropic medications","author":"Goldberg","year":"2019"},{"key":"10.1016\/j.psym.2020.05.006_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4292\/wjgpt.v8.i1.26","article-title":"Psychotropic drugs and liver disease: a critical review of pharmacokinetics and liver toxicity","volume":"8","author":"Telles-Correia","year":"2017","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.psym.2020.05.006_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13054-020-02872-z","article-title":"Acute kidney injury in SARS-CoV-2 infected patients","volume":"24","author":"Fanelli","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.psym.2020.05.006_bib21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.psym.2020.05.006_bib22","first-page":"e201127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.psym.2020.05.006_bib23","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.psym.2020.05.006_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-02882-x","article-title":"COVID-19: ICU delirium management during SARS-CoV-2 pandemic","volume":"24","author":"Kotfis","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.psym.2020.05.006_bib25","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.4088\/JCP.15m09898","article-title":"Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders","volume":"77","author":"Wu","year":"2016","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.psym.2020.05.006_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.yebeh.2016.01.029","article-title":"Proconvulsant effects of antidepressants \u2014 what is the current evidence?","volume":"61","author":"Johannessen Landmark","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.psym.2020.05.006_bib27","doi-asserted-by":"crossref","first-page":"101615","DOI":"10.1016\/j.tmaid.2020.101615","article-title":"Remdesivir as a possible therapeutic option for the COVID-19","volume":"34","author":"Al-Tawfiq","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.psym.2020.05.006_bib30","article-title":"Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States","author":"COVID-19 Investigation Team","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.psym.2020.05.006_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105945","article-title":"Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine","volume":"55","author":"Sahraei","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.psym.2020.05.006_bib32","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.psym.2020.05.006_bib33","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","author":"Geleris","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.psym.2020.05.006_bib34","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1176\/ajp.134.7.798","article-title":"Behavioral toxicity and equivocal suicide associated with chloroquine and its derivatives","volume":"134","author":"Good","year":"1977","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psym.2020.05.006_bib36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10787-018-0498-5","article-title":"Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article","volume":"26","author":"Mascolo","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.psym.2020.05.006_bib37","first-page":"545","article-title":"Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus","volume":"36","author":"McGhie","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.psym.2020.05.006_bib39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gut.35.4.569","article-title":"Fulminant hepatic failure secondary to hydroxychloroquine","volume":"35","author":"Makin","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.psym.2020.05.006_bib40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5114\/ada.2018.77675","article-title":"Seizures as a rare adverse effect of chloroquine therapy in systemic lupus erythematosus patients: a case report and literature survey","volume":"35","author":"Krzeminski","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.psym.2020.05.006_bib41","series-title":"Pharmacology of chloroquine and hydroxychloroquine BT - hydroxychloroquine and chloroquine retinopathy","first-page":"35","author":"Browning","year":"2014"},{"key":"10.1016\/j.psym.2020.05.006_bib42","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (actemra)","volume":"13","author":"Sheppard","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.psym.2020.05.006_bib44","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.psym.2020.05.006_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3899\/jrheum.100717","article-title":"Tocilizumab for rheumatoid arthritis: a Cochrane systematic review","volume":"38","author":"Singh","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.psym.2020.05.006_bib46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40744-017-0081-3","article-title":"Impact of tocilizumab monotherapy on clinical and patient-reported quality-of-life outcomes in patients with rheumatoid arthritis","volume":"4","author":"Harrold","year":"2017","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.psym.2020.05.006_bib47","series-title":"Inflammation and the brain: tocilizumab may redefine our understanding of depression and related symptoms in the medically ill","author":"Knight","year":"2018"},{"key":"10.1016\/j.psym.2020.05.006_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus\u00a0disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.psym.2020.05.006_bib49","doi-asserted-by":"crossref","first-page":"e0006034","DOI":"10.1371\/journal.pntd.0006034","article-title":"QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient","volume":"11","author":"Chinello","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.psym.2020.05.006_bib51","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A\u00a0trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.psym.2020.05.006_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40263-013-0132-4","article-title":"Neurological and psychiatric adverse effects of antiretroviral drugs","volume":"28","author":"Abers","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psym.2020.05.006_bib53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/S109285291800113X","article-title":"Drug\u2013drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs","volume":"24","author":"Goodlet","year":"2019","journal-title":"CNS Spectr"},{"key":"10.1016\/j.psym.2020.05.006_bib54","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1473-3099(20)30141-9","article-title":"Convalescent plasma as a potential therapy for COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.psym.2020.05.006_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-020-2818-6","article-title":"Treatment of COVID-19: old tricks for new challenges","volume":"24","author":"Cunningham","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.psym.2020.05.006_bib56","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1111\/j.1537-2995.2012.03663.x","article-title":"Adverse effects of plasma transfusion","volume":"52","author":"Pandey","year":"2012","journal-title":"Transfus"},{"key":"10.1016\/j.psym.2020.05.006_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/cid\/civ680","article-title":"The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: a perspective from the field","volume":"62","author":"Van Griensven","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.psym.2020.05.006_bib58","article-title":"Ethics of using convalescent whole blood and convalescent plasma during the Ebola epidemic: interim guidance for ethics review committees, researchers, national health authorities and blood transfusion services.","author":"World Health Organization","year":"2015","journal-title":"World Health Organization"},{"key":"10.1016\/j.psym.2020.05.006_bib60","first-page":"22","article-title":"Azithromycin-induced psychotic depression and catatonia","volume":"13","author":"Ginsberg","year":"2006","journal-title":"Prim Psychiatry"},{"key":"10.1016\/j.psym.2020.05.006_bib61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s15010-009-9179-z","article-title":"Hepatotoxicity of antibacterials: pathomechanisms and clinical data","volume":"38","author":"Leitner","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.psym.2020.05.006_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1742-4658.2006.05607.x","article-title":"Vitamin C","volume":"274","author":"Linster","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.psym.2020.05.006_bib63","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.11825","article-title":"Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial","volume":"322","author":"Truwit","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.psym.2020.05.006_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/antiox7070091","article-title":"High vitamin C status is associated with elevated mood in male tertiary students","volume":"7","author":"Pullar","year":"2018","journal-title":"Antioxidants"},{"key":"10.1016\/j.psym.2020.05.006_bib65","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.eurger.2014.09.002","article-title":"Vitamin deficiency as a risk factor for delirium","volume":"6","author":"Torbergsen","year":"2015","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.psym.2020.05.006_bib66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psym.2011.12.007","article-title":"The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited","volume":"53","author":"Dubovsky","year":"2012","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psym.2020.05.006_bib67","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.psym.2020.05.006_bib68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1056-4993(18)30135-4","article-title":"Cytochrome P450-mediated drug interactions","volume":"9","author":"Flockhart","year":"2000","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.psym.2020.05.006_bib69","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002280100340","article-title":"Effect of methylprednisolone on CYP3A4-mediated drug metabolism in\u00a0vivo","volume":"57","author":"Villikka","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.psym.2020.05.006_bib70","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(78)90938-8","article-title":"Phenytoin\/dexamethasone interaction: a clinical problem","volume":"311","author":"McLelland","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.psym.2020.05.006_bib71","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archneur.1994.00540240089022","article-title":"A\u00a0brief history of the use of interferons as treatment of multiple sclerosis","volume":"51","author":"Jacobs","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psym.2020.05.006_bib72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3201\/eid1002.030482","article-title":"Interferon-\u03b2 1a and SARS coronavirus replication","volume":"10","author":"Hensley","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.psym.2020.05.006_bib73","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/382597","article-title":"Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-\u03b1","volume":"189","author":"Str\u00f6her","year":"2004","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.psym.2020.05.006_bib74","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/JCMA.0000000000000318","article-title":"Potential therapeutic agents against COVID-19: what we know so far","volume":"83","author":"Lu","year":"2020","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.psym.2020.05.006_bib76","first-page":"971","article-title":"Psychiatric side effects of pegylated interferon-\u03b1 and ribavirin therapy in Iranian patients with chronic hepatitis C: a meta-analysis","volume":"16","author":"Davoodi","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.psym.2020.05.006_bib77","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/jir.2013.0158","article-title":"How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms","volume":"34","author":"Reder","year":"2014","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.psym.2020.05.006_bib78","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MCG.0b013e3181f656fb","article-title":"Seizures during pegylated interferon and ribavirin therapy for chronic Hepatitis C: observations from the WIN-R trial","volume":"45","author":"Ahmed","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"suppl_l","key":"10.1016\/j.psym.2020.05.006_bib79","first-page":"i4","article-title":"Update on colchicine, 2017","volume":"57","author":"Slobodnick","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.psym.2020.05.006_bib80","author":"Tardif"},{"key":"10.1016\/j.psym.2020.05.006_bib81","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.psym.2020.05.006_bib82","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","article-title":"Colchicine: its mechanism of action and efficacy in crystal-induced inflammation","volume":"10","author":"Nuki","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.psym.2020.05.006_bib83","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.sleep.2020.04.006","article-title":"Delirium and sleep disturbances in COVID\u201319: a possible role for melatonin in hospitalized patients?","volume":"70","author":"Zambrelli","year":"2020","journal-title":"Sleep Med"},{"key":"10.1016\/j.psym.2020.05.006_bib84","author":"Gordon"},{"key":"10.1016\/j.psym.2020.05.006_bib85","doi-asserted-by":"crossref","first-page":"eaau5266","DOI":"10.1126\/scitranslmed.aau5266","article-title":"Modulation of the sigma-1 receptor\u2013IRE1 pathway is beneficial in preclinical models of inflammation and sepsis","volume":"11","author":"Rosen","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.psym.2020.05.006_bib86","doi-asserted-by":"crossref","first-page":"117583","DOI":"10.1016\/j.lfs.2020.117583","article-title":"COVID-19: melatonin as\u00a0a\u00a0potential adjuvant treatment","volume":"250","author":"Zhang","year":"2020","journal-title":"Life Sci"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318220301444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318220301444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:27:07Z","timestamp":1758500827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318220301444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0033318220301444"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2020.05.006","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychopharmacology of COVID-19","name":"articletitle","label":"Article Title"},{"value":"Psychosomatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psym.2020.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}